Impact of CD14++CD16+ monocytes on plaque vulnerability in diabetic and non-diabetic patients with asymptomatic coronary artery disease: a cross-sectional study

Table 2 Plaque characteristics, evaluated by VH-IVUS

	Total N = 82	DM N = 38	Non-DM N = 44	p value DM vs. non-DM
Plaque location				0.91
LAD	38 (46)	18 (47)	20 (45)
LCx	16 (20)	6 (16)	10 (23)
RCA	24 (29)	12 (32)	12 (27)
LMT	4 (5)	2 (5)	2 (5)
Plaque volume
Absolute data, mm³	148.3 ± 114.8	148.3 ± 114.8	114.1 ± 108.4	0.17
Plaque burden, %	55.5 ± 7.1	56.7 ± 7.6	54.1 ± 6.6	0.10
Lesion length, mm	16.7 ± 13.2	17.9 ± 13.5	16.0 ± 12.2	0.51
Fibrous
Absolute data, mm³	45.1 ± 46.5	50.6 ± 39.0	41.9 ± 50.6	0.39
Plaque burden, %	54.8 ± 10.6	53.5 ± 10.2	56.8 ± 10.4	0.15
Fibrofatty
Absolute data, mm³	10.1 ± 10.4	11.8 ± 11.2	9.7 ± 10.6	0.41
Plaque burden, %	12.1 ± 5.6	11.7 ± 5.0	13.2 ± 6.1	0.26
Dense calcium
Absolute data, mm³	10.0 ± 12.5	13.0 ± 15.3	6.6 ± 7.3	0.023
Plaque burden, %	11.5 ± 7.4	12.6 ± 7.9	9.6 ± 6.6	0.06
Necrotic core
Absolute data, mm³	18.1 ± 17.8	21.4 ± 18.2	14.6 ± 15.7	0.07
Plaque burden, %	21.6 ± 6.8	22.2 ± 5.3	20.4 ± 7.9	0.25
Thin-cap fibroatheromas	15 (18)	10 (26)	5 (11)	0.08

Data are represented as mean ± standard deviation, or as counts (%)
DM diabetes mellitus, LAD left anterior descending coronary artery, LCx left circumflex artery, LMT left main trunk, RCA right coronary artery

ISSN: 1475-2840